{
  "title": "What this review means",
  "includeSubclaimIllustrations": false,
  "redteamReviewed": true,
  "accessNotice": "Source checking used bounded original primary abstract passages/status records and selected original partial-body passages. No complete-abstract or complete-paper audit, or independent scientific peer review, is claimed. Detailed access counts and limitations appear in the review.",
  "overview": "Specific microbial exposures can shape immune regulation and prevent some eczema; a generalized hygiene-to-allergy-and-autoimmunity causal chain is not established.",
  "implications": "Overall Γ follows the registered complete human incidence SC3, with SC1 at Β and exposure-specific immune/clinical SC2 at Ε. Positive eczema trials and mechanistic recipient experiments are retained without claiming generalized protection from asthma or autoimmunity. Neither a universal biomarker cap nor a negative-trial veto is imposed on the narrow clinical successes; the broad conjunction has not crossed its own causal boundary.",
  "limitations": "63 primary reports with 6 selected partial-body examinations; density, heterogeneous controls and incomplete access set the confidence, not correctness. The grade applies to the exact registered claim; stronger findings for narrower subclaims remain separate. No complete-paper audit or blinded calibration is claimed. This educational review does not establish an individual treatment recommendation."
}